| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $820K | -26.8% | -26.2% |
| Cost of Revenue | $636K | -11.3% | -2.3% |
| Gross Profit | $184K | -54.3% | -60.0% |
| R&D Expense | $631K | +8.4% | -40.5% |
| SG&A Expense | $1.6M | +5.8% | +4.3% |
| Pre-tax Income | -$2.0M | -17.4% | +21.2% |
| Net Income | -$2.0M | -17.4% | +21.2% |
| EPS (Basic) | -$0.51 | -15.9% | +86.0% |
| EPS (Diluted) | -$0.51 | -15.9% | +86.0% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $7.0M | -25.5% | +103.4% |
| Short-term Investments | $43K | -0.4% | +4.6% |
| Accounts Receivable | $183K | -46.7% | -30.3% |
| Inventory | $948K | +6.4% | -14.1% |
| Current Assets | $8.8M | -18.6% | +60.7% |
| Total Assets | $11.2M | -16.2% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$4.0M | -147.8% | — |
| Financing Cash Flow | -$137K | +0.0% | — |
| +31.6% |
| Current Liabilities | $1.5M | -4.8% | -17.4% |
| Total Liabilities | $1.6M | -9.4% | -30.9% |
| Stockholders' Equity | $9.6M | -17.3% | +55.1% |